Combination antitumor therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/28 (2006.01) A61K 31/337 (2006.01) A61K 31/47 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2724550

The present disclosure relates to methods of treating cancers that are responsive to antimetabolite or antimitotic anti-cancer agents. The methods involve the use of at least one anti-cancer agent selected from antimetabolite anti-cancer agents, antimitotic anti-cancer agents, and combinations thereof, and a superoxide dismutase mimetic to potentiate the therapeutic effect of the anti cancer agent(s).

La présente invention concerne des procédés de traitement de cancers qui sont sensibles à des agents anticancéreux anti-métabolites ou antimitotiques. Les procédés entraînent lutilisation dau moins un agent anticancéreux choisi parmi les agents anticancéreux anti-métabolites, les agents anticancéreux antimitotiques et leurs combinaisons, et une substance mimétique de superoxyde dismutase pour potentialiser leffet thérapeutique du ou des agents anticancéreux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination antitumor therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination antitumor therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination antitumor therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1723224

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.